Boustead report stated Pharma had Q1 surplus 29.4m due to accelerated amortization of 247.3m from rights to supply, sales demand increase in Indonesia and our MoH concession due to covid, and cost cutting measures. we can expect similar or better Q2 surplus from no more need to amortized rights to supply and higher demand in Indonesia than more demand here due to covid situation even before vaccine.
Last year dpharma extend their contract for insulin product (dec 2020) and pharmateciucal supply (dec 2021) to gov and dpharma also have vaccine facility. Dpharma has good chances to be the vaccine distributers. Dpharma already in fill and finish business way before when they FF the insulin product from Biocon. They already have the capacity for the vaccine. So high chances Dpharma will have the contract.
@DrLimKH ,tht only can said that period nothing happen in disposed or acquired..why said deleted the record?Do you mean had happend but the record delete by bursa?
Commenting further, Khairy said he had personally visited both the production facilities and found that they had the capacity to carry out the bottling process.
"They are the two companies that have accredited fill and finish capabilities in Malaysia. The Duopharma fill and finish facility is not being used but Pharmaniaga's is being used
Khairy added that the government was also ready to offer the service to other countries.
"For example, we will work with Correlation of Epidemic Preparedness and Innovation to offer our fill and finish facility for other countries that don't have the facility once we have done it for our people," he said.
Hence, to answer question on whether the FF market is limited to Malaysia. The answer is No.
DrLimKH Commenting further, Khairy said he had personally visited both the production facilities and found that they had the capacity to carry out the bottling process.
"They are the two companies that have accredited fill and finish capabilities in Malaysia. The Duopharma fill and finish facility is not being used but Pharmaniaga's is being used
It means pharma FF is occupied already. Unlike dpharma open for use.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DrLimKH
432 posts
Posted by DrLimKH > 2020-08-09 14:18 | Report Abuse
Boustead report stated Pharma had Q1 surplus 29.4m due to accelerated amortization of 247.3m from rights to supply, sales demand increase in Indonesia and our MoH concession due to covid, and cost cutting measures.
we can expect similar or better Q2 surplus from no more need to amortized rights to supply and higher demand in Indonesia than more demand here due to covid situation even before vaccine.
We don't know when pharma will start fill and pack covid vaccine as it already doing that since 2011 while Duopharma (and seems APexH also) will start end 2021. So looks like only Pharma can do this now.
https://www.pharmaceutical-technology.com/projects/pharmaniaga-small-volume-injectables-svi-facility/